30 related articles for article (PubMed ID: 16965676)
1. Chaperonin CCT-mediated AIB1 folding promotes the growth of ERα-positive breast cancer cells on hard substrates.
Chen L; Zhang Z; Qiu J; Zhang L; Luo X; Jang J
PLoS One; 2014; 9(5):e96085. PubMed ID: 24788909
[TBL] [Abstract][Full Text] [Related]
2. Selective impact of ALK and MELK inhibition on ERα stability and cell proliferation in cell lines representing distinct molecular phenotypes of breast cancer.
Bartoloni S; Pescatori S; Bianchi F; Cipolletti M; Acconcia F
Sci Rep; 2024 Apr; 14(1):8200. PubMed ID: 38589728
[TBL] [Abstract][Full Text] [Related]
3. Investigating the effect of hesperetin on estrogen receptor alpha (ERα) expression, phosphorylation and activity in MCF-7 cells.
Vosooghi R; Motavalizadehkakhky A; Mansouri A; Mehrzad J; Homayouni M
Gene; 2024 Jun; 911():148357. PubMed ID: 38462023
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor alpha (ER alpha) mRNA copy numbers in immunohistochemically ER alpha-positive-, and negative breast cancer tissues.
Poola I; Yue Q
BMC Cancer; 2007 Mar; 7():56. PubMed ID: 17391528
[TBL] [Abstract][Full Text] [Related]
5. Network-informed discovery of multidrug combinations for ERα+/HER2-/PI3Kα-mutant breast cancer.
Hany D; Zoetemelk M; Bhattacharya K; Nowak-Sliwinska P; Picard D
Cell Mol Life Sci; 2023 Mar; 80(3):80. PubMed ID: 36869202
[TBL] [Abstract][Full Text] [Related]
6. Effects of matcha tea extract on cell viability and estrogen receptor-β expression on MCF-7 breast cancer cells.
Keckstein S; Tilgener C; Jeschke U; Hofmann S; Vilsmaier T; Keilmann L; Heidegger H; Kaltofen T; Batz F; Mahner S; Schröder L
Arch Gynecol Obstet; 2024 Apr; 309(4):1509-1514. PubMed ID: 37737883
[TBL] [Abstract][Full Text] [Related]
7. Revealing Propolis Potential Activity on Inhibiting Estrogen Receptor and Heat Shock Protein 90 Overexpressed in Breast Cancer by Bioinformatics Approaches.
Simanjuntak MV; Jauhar MM; Syaifie PH; Arda AG; Mardliyati E; Shalannanda W; Hermanto BR; Anshori I
Bioinform Biol Insights; 2024; 18():11779322231224187. PubMed ID: 38274992
[TBL] [Abstract][Full Text] [Related]
8. Exploration and biological evaluation of 20-vinyl pregnenes: A step forward toward selective modulators of the estrogen receptor α signaling for breast cancer treatment.
Malakhova V; Scherbakov A; Sorokin D; Leanavets H; Dzichenka Y; Zavarzin I; Volkova Y
Arch Pharm (Weinheim); 2024 Apr; ():e2300651. PubMed ID: 38570819
[TBL] [Abstract][Full Text] [Related]
9. Carbamazepine promotes Her-2 protein degradation in breast cancer cells by modulating HDAC6 activity and acetylation of Hsp90.
Meng Q; Chen X; Sun L; Zhao C; Sui G; Cai L
Mol Cell Biochem; 2011 Feb; 348(1-2):165-71. PubMed ID: 21082217
[TBL] [Abstract][Full Text] [Related]
10. Magnetic layered double hydroxides with carbamazepine for breast cancer treatment.
Peralta MF; Mendieta SN; Scolari IR; Gerbaldo MV; Oliva MI; Gil GA; Granero GE; Crivello ME
Heliyon; 2023 Oct; 9(10):e21030. PubMed ID: 37916071
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and release behavior of layered double hydroxides-carbamazepine composites.
Peralta MF; Mendieta SN; Scolari IR; Granero GE; Crivello ME
Sci Rep; 2021 Oct; 11(1):20585. PubMed ID: 34663824
[TBL] [Abstract][Full Text] [Related]
12. Targeting the pH Paradigm at the Bedside: A Practical Approach.
Koltai T
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287221
[TBL] [Abstract][Full Text] [Related]
13. Time to focus on brain tumor-related epilepsy trials.
Gallagher P; Leach JP; Grant R
Neurooncol Pract; 2014 Sep; 1(3):123-133. PubMed ID: 31386030
[TBL] [Abstract][Full Text] [Related]
14. Voltage-gated sodium channel as a target for metastatic risk reduction with re-purposed drugs.
Koltai T
F1000Res; 2015; 4():297. PubMed ID: 27408684
[TBL] [Abstract][Full Text] [Related]
15. [Inhibitory effect of carbamazepine on proliferation of estrogen-dependent breast cancer cells].
Meng QW; Zhao CH; Xi YH; Cai L; Sun LC; Sui GJ
Ai Zheng; 2006 Aug; 25(8):967-73. PubMed ID: 16965676
[TBL] [Abstract][Full Text] [Related]
16. [Enhancement of HER-2 degradation by carbamazepine in breast cancer SKBR-3 cell line].
Meng QW; Zhao CH; Xi YH; Cai L; Sun LC; Sui GJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):503-6. PubMed ID: 17147113
[TBL] [Abstract][Full Text] [Related]
17. Leptin attenuates the anti-estrogen effect of tamoxifen in breast cancer.
Chen X; Zha X; Chen W; Zhu T; Qiu J; Røe OD; Li J; Wang Z; Yin Y
Biomed Pharmacother; 2013 Feb; 67(1):22-30. PubMed ID: 23199901
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor trichostatin A represses estrogen receptor alpha-dependent transcription and promotes proteasomal degradation of cyclin D1 in human breast carcinoma cell lines.
Alao JP; Lam EW; Ali S; Buluwela L; Bordogna W; Lockey P; Varshochi R; Stavropoulou AV; Coombes RC; Vigushin DM
Clin Cancer Res; 2004 Dec; 10(23):8094-104. PubMed ID: 15585645
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
Al-Dhaheri MH; Rowan BG
Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]